This study aimed to assess the effect of natural compounds on MASLD and to explore the role of key autophagy related proteins (CD36, PLIN-3) in the disease’s progression and potential therapeutic modulation. Here, PLIN3 is linked to metabolic dysfunction-associated steatotic liver disease.